Activation of PPARδ alters lipid metabolism in db/db mice

被引:277
|
作者
Leibowitz, MD
Fiévet, C
Hennuyer, N
Peinado-Onsurbe, J
Duez, H
Berger, J
Cullinan, CA
Sparrow, CP
Baffic, J
Berger, GD
Santini, C
Marquis, RW
Tolman, RL
Smith, RG
Moller, DE
Auwerx, J
机构
[1] Merck Res Labs, Dept Lipid Biochem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[3] Inst Pasteur Lille, INSERM, U325, F-59019 Lille, France
[4] Merck Res Labs, Dept Mol Endocrinol, Rahway, NJ 07065 USA
关键词
peroxisome proliferator-activated receptor delta agonist; peroxisome proliferator-activated receptor; lipid metabolism;
D O I
10.1016/S0014-5793(00)01554-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors, which heterodimerize with the retinoid X receptor and bind to peroxisome proliferator response elements in the promoters of regulated genes. Despite the wealth of information available on the function of PPAR alpha and PPAR gamma, relatively little is known about the most widely expressed PPAR subtype, PPAR delta. Here we show that treatment of insulin resistant db/db mice with the PPAR delta agonist L-165041, at doses that had no effect on either glucose or triglycerides, raised total plasma cholesterol concentrations. The increased cholesterol was primarily associated,vith high density lipoprotein (HDL) particles, as shown by fast protein liquid chromatography analysis. These data,were corroborated by the chemical analysis of the lipoproteins isolated by ultracentrifugation, demonstrating that treatment with L-165041 produced an increase in circulating HDL without major changes in very low or low density lipoproteins. White adipose tissue lipoprotein lipase activity,vas reduced following treatment with the PPAR delta ligand, but was increased by a PPAR gamma agonist. These data suggest both that PPAR delta is involved in the regulation of cholesterol metabolism in db/db mice and that PPAR delta ligands could potentially have therapeutic value. (C) 2000 Federation of European Biochemical Societies.
引用
收藏
页码:333 / 336
页数:4
相关论文
共 50 条
  • [21] Bavachinin, as a novel natural pan-PPAR agonist, exhibits unique synergistic effects with synthetic PPAR-γ and PPAR-α agonists on carbohydrate and lipid metabolism in db/db and diet-induced obese mice
    Li Feng
    Huan Luo
    Zhijian Xu
    Zhuo Yang
    Guoxin Du
    Yu Zhang
    Lijing Yu
    Kaifeng Hu
    Weiliang Zhu
    Qingchun Tong
    Kaixian Chen
    Fujiang Guo
    Cheng Huang
    Yiming Li
    Diabetologia, 2016, 59 : 1276 - 1286
  • [22] Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db/db mice
    Yang, Hao
    Yang, Tingting
    Heng, Cai
    Zhou, Yi
    Jiang, Zhenzhou
    Qian, Xuan
    Du, Lei
    Mao, Shiyu
    Yin, Xiaoxing
    Lu, Qian
    PHYTOTHERAPY RESEARCH, 2019, 33 (12) : 3140 - 3152
  • [23] Grape seed procyanidin B2 ameliorates hepatic lipid metabolism disorders in db/db mice
    Yin, Mei
    Zhang, Pei
    Yu, Fei
    Zhang, Zhen
    Cai, Qian
    Lu, Weida
    Li, Baoying
    Qin, Weidong
    Cheng, Mei
    Wang, Hao
    Gao, Haiqing
    MOLECULAR MEDICINE REPORTS, 2017, 16 (03) : 2844 - 2850
  • [24] Blockade of Cannabinoid Receptor 1 Improves Insulin Resistance, Lipid Metabolism, and Diabetic Nephropathy in db/db Mice
    Nam, D. H.
    Lee, M. H.
    Kim, J. E.
    Song, H. K.
    Kang, Y. S.
    Lee, J. E.
    Kim, H. W.
    Cha, J. J.
    Hyun, Y. Y.
    Kim, S. H.
    Han, S. Y.
    Han, K. H.
    Han, J. Y.
    Cha, Dae Ryong
    ENDOCRINOLOGY, 2012, 153 (03) : 1387 - 1396
  • [25] Chlorogenic acid improves glucose tolerance, lipid metabolism, inflammation and microbiota composition in diabetic db/db mice
    Yan, Yongwang
    Li, Qing
    Shen, Ling
    Guo, Kangxiao
    Zhou, Xu
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [26] Effect of Chinese prescription Kangen-karyu on lipid metabolism in type 2 diabetic db/db mice
    Yamabe, Noriko
    Kim, Hyun Young
    Kang, Ki Sung
    Zhao, Qi
    Matsumoto, Kinzo
    Yokozawa, Takako
    JOURNAL OF ETHNOPHARMACOLOGY, 2010, 129 (03) : 299 - 305
  • [27] Chungkukjang supplementaion enhances glucose and lipid metabolism in C57BL/KsJ db/db mice
    Kim, Dong-Ju
    Jeong, Yong-Jin
    Kwon, Joong-Ho
    Choi, Myung-Sook
    FASEB JOURNAL, 2007, 21 (06): : A1089 - A1089
  • [28] Combination therapy with PPARγ and PPARα agonists increases glucose-stimulated insulin secretion in db/db mice
    Yajima, K
    Hirose, H
    Fujita, H
    Seto, Y
    Fujita, H
    Ukeda, K
    Miyashita, K
    Kawai, T
    Yamamoto, Y
    Ogawa, T
    Yamada, T
    Saruta, T
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 284 (05): : E966 - E971
  • [29] Tankyrase inhibition ameliorates lipid disorder in diabetic db/db mice
    Wang, H.
    Kuusela, S.
    Ramadan, U. A.
    Waaler, J.
    Dumont, V.
    Linden, A. -M.
    Chi, N. -W.
    Krauss, S.
    Lehtonen, S.
    DIABETOLOGIA, 2017, 60 : S34 - S34
  • [30] Astragaloside IV ameliorates metabolic disorder in db/db obese mice as a PPARγ antagonist
    Wu, Hui
    Wang, Gao-Rui
    Wang, Xin-Ting
    Bai, Yu-Yan
    Yuan, Jin-Feng
    Yang, Liu
    Huang, Fei
    Shi, Hai-Lian
    Wu, Xiao-Jun
    JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 2023, 25 (05) : 484 - 496